201 related articles for article (PubMed ID: 36252582)
1. Developing an effective and sustainable national immunisation programme in China: issues and challenges.
Chen S; Yao L; Wang W; Tang S
Lancet Public Health; 2022 Dec; 7(12):e1064-e1072. PubMed ID: 36252582
[TBL] [Abstract][Full Text] [Related]
2. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
Chen S; Rodewald LE; Du AH; Tang S
Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849
[TBL] [Abstract][Full Text] [Related]
3. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
4. Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
Dai P; Wang Q; Jia M; Leng Z; Xie S; Feng L; Yang W
Hum Vaccin Immunother; 2023 Dec; 19(1):2194190. PubMed ID: 37099400
[TBL] [Abstract][Full Text] [Related]
5. System within systems: challenges and opportunities for the Expanded Programme on Immunisation in Pakistan.
Haq Z; Shaikh BT; Tran N; Hafeez A; Ghaffar A
Health Res Policy Syst; 2019 May; 17(1):51. PubMed ID: 31101060
[TBL] [Abstract][Full Text] [Related]
6. Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.
Rodewald LE
Infect Dis Poverty; 2023 Oct; 12(1):96. PubMed ID: 37845759
[TBL] [Abstract][Full Text] [Related]
7. Immunisation program reviews in East and Southern Africa: 2012-2018; key lessons.
Shibeshi ME; Masresha BG; Daniel F
Pan Afr Med J; 2020; 37():385. PubMed ID: 33796198
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
Yu W; Lee LA; Liu Y; Scherpbier RW; Wen N; Zhang G; Zhu X; Ning G; Wang F; Li Y; Hao L; Zhang X; Wang H
Vaccine; 2018 Dec; 36(52):8131-8137. PubMed ID: 30497834
[TBL] [Abstract][Full Text] [Related]
9. Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China.
Ma J; Li Z; Sun Y; Liu Z; Dang Y; Huang Y
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497631
[TBL] [Abstract][Full Text] [Related]
10. Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee.
JAMA; 1999 Jul; 282(4):363-70. PubMed ID: 10432034
[TBL] [Abstract][Full Text] [Related]
11. How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.
Jiang H; Wei C
Front Public Health; 2024; 12():1286801. PubMed ID: 38317799
[TBL] [Abstract][Full Text] [Related]
12. Childhood vaccination: achievements and challenges.
Ndumbe P
Afr Health; 1996 Sep; 18(6):18-9. PubMed ID: 12291732
[TBL] [Abstract][Full Text] [Related]
13. The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade.
Lindstrand A; Cherian T; Chang-Blanc D; Feikin D; O'Brien KL
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S452-S467. PubMed ID: 34590130
[TBL] [Abstract][Full Text] [Related]
14. Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
Feiring B; Laake I; Molden T; Håberg SE; Nøkleby H; Seterelv SS; Magnus P; Trogstad L
Vaccine; 2016 Apr; 34(17):2015-20. PubMed ID: 26947498
[TBL] [Abstract][Full Text] [Related]
15. National immunization programmes.
Cherian T; Mantel C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):16-24. PubMed ID: 31792552
[TBL] [Abstract][Full Text] [Related]
16. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
De Waure C; Sisti LG; Poscia A; Ricciardi W
Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
[TBL] [Abstract][Full Text] [Related]
17. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
18. Immunisation program reviews in East and Southern Africa (2012-2018): key lessons.
Shibeshi ME; Masresha BG; Daniel F
Pan Afr Med J; 2021; 38():194. PubMed ID: 33995800
[TBL] [Abstract][Full Text] [Related]
19. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
20. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005-2021.
Liu X; Yu W; Yin Z; Rodewald L; Song Y; Zhang Z; Ye J; Li L; Cao L; Cao L
Vaccine; 2022 Apr; 40(18):2561-2567. PubMed ID: 35339307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
